PharmaTech

JUNE 24, 2025

Intellia Therapeutics Announces First Patient Dosed in the Phase 3 MAGNITUDE Study of NTLA-2001 as a Single-Dose CRISPR-Based Treatment for Transthyretin Amyloidosis with Cardiomyopathy. News Release. Intellia Therapeutics. News Release. BioNTech Announces First Quarter 2025 Financial Results and Corporate Update | BioNTech.

Vaccines 59

Vaccines Dosage Drug Development Immunity 59

RX Note

MARCH 31, 2025

External Links American Academy of Dermatology Association - Cold Sores Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture, 2001 Natural remedies for Herpes simplex, 2006 Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis, (..)

Community Pharmacies 52

Community Pharmacies Chemotherapy 52

Pharmaceutical Technology

JULY 11, 2025

July 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook AbbVie will gain exclusive rights to develop, manufacture and market ISB 2001 across several major regions. Credit: JHVEPhoto/Shutterstock. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate?

Packaging 52

Packaging Hospitals Communication Drug Pricing 52

Safe Biologics

JULY 7, 2025

Department of Health and Services (HHS) from 2001 to 2008. ARLINGTON, VA — July 7, 2025 — The Alliance for Safe Biologic Medicines (ASBM) today announced the retirement of longtime Board member Doug Badger, and the appointment of two new members to its Board of Directors: Cristina V.

113

113

COE Integrated Care

MAY 23, 2024

Gatekeepers (Surgeon General’s National Strategy for Suicide Prevention, 2001) are those who are able to recognize a crisis and the warning signs that someone may be contemplating suicide and this can include first response, ministers and priests, teachers, neighbors, friends, parents, doctors, nurses, office supervisors, and more.

52

52

Pharmaceutical Technology

JUNE 26, 2025

I call on Gavi today to re-earn the public trust and to justify the $8bn that America has provided in funding since 2001,” he said in a video statement. In a move that reflects the country’s ongoing pullback from international aid , US health secretary Robert F Kennedy, Jr (RFK) claimed Gavi had ignored science. “I

Vaccines 59

Vaccines Packaging Communication Hospitals 59

Beckers Hospital Review

JULY 11, 2025

Mr. Mikitarian has led Parrish Medical Center as its president and CEO since 2001. She joined Holland as a staff nurse in 1987, serving in various leadership roles before joining the executive team as vice president of nursing and chief nursing officer in 2001. He helped open Aurora BayCare Health Center in Kaukauna, Wis.,

Hospitals 119

Hospitals Inpatient Communication Nursing Homes 119

World Pharma News

JULY 1, 2025

The study, coordinated by researchers from the Barcelona Institute for Global Health (ISGlobal), together with the Institute of Collective Health of the Federal University of Bahia (ISC-UFBA), the University of California Los Angeles (UCLA), and the Manhiça Centre for Health Research (CISM), among others, estimates that 91 million deaths were prevented (..)

44

44

STAT

JULY 10, 2025

The drug, called ISB 2001, targets CD38 and BCMA protein receptors on tumor cells and the CD3 receptor on T cells. AbbVie is paying $700 million upfront to acquire licensing rights to a “trispecific antibody” treatment for cancer developed by Ichnos Global Innovation. A Phase 1 study in multiple myeloma is underway.

Biosimilars 160

Biosimilars Drug Pricing Drug Development 160

Beckers Hospital Review

JULY 18, 2025

Peter’s Healthcare in 2001 as director of service excellence, a role in which she served 15 years. Chief Experience Officer and Vice President of Marketing Communication for Saint Peter’s Healthcare System (New Brunswick, N.J.). Drumbore joined St. She was appointed vice president and chief experience officer of the system in May 2016.

Hospitals 52

Hospitals Communication Customer Service Inpatient 52

Pharmacy Times

MAY 8, 2025

The agent demonstrated promising tolerability and manageable safety.

32

32

Beckers Hospital Review

JULY 2, 2025

He joined Franciscan in 2001 during his residency and has served in various leadership roles, most recently as medical director of information services. He previously served as CEO of Presence Health, where he led a $210 million financial turnaround. Joseph Schnecker, MD, has been promoted to chief medical information officer.

Hospitals 52

Hospitals 52

STAT

JULY 9, 2024

But that’s not how it turned out: One individual’s DNA accounted for the vast majority of the genome when a first draft was released in 2001. Read the rest…

336

336

STAT

NOVEMBER 24, 2023

In 2001, at the age of 13, I had come to Kenya’s largest informal settlement on the outskirts of Nairobi with my sister. I had only lived in Kibera for 15 minutes when I saw a police officer and was arrested. But it would be years before I saw a real doctor. When we arrived at 3 a.m.,

319

319

STAT

APRIL 10, 2024

stood at 323 during the fourth quarter of last year — the highest figure reached since such data began being tracked in 2001 — underscoring growing concerns about patient harm across the country. The number of ongoing and active drug shortages in the U.S.

Chemotherapy 356

Chemotherapy Immunity Immunization 356

STAT

MAY 30, 2024

at epidemic rates that have been climbing since 2001. Syphilis, one of the oldest infections known to humans, has returned to the U.S. In 2022, the last year with complete data, the highest number of infections were recorded in more than 70 years.

362

362

STAT

JANUARY 10, 2023

Five studies co-authored by Tessier-Lavigne are now under the microscope for containing alleged altered images: a 1999 Cell study , a 2008 paper in the EMBO Journal, a 2003 Nature study, and two studies published in 2001 in Science.

343

343

STAT

AUGUST 31, 2023

The retractions come the same day that Tessier-Lavigne’s resignation as Stanford president takes effect.

355

355

STAT

JUNE 5, 2024

” Here is the back story: In 2001, Gilead won U.S. For its part, the company issued a statement in which it did not admit wrongdoing and continued to maintain it has “never stopped working to improve the lives of people with HIV.”

361

361

STAT

MARCH 31, 2023

Indeed, academic inventors or founders contributed to more than one-quarter of all medicines approved from 2001 through 2019. Academia can be an excellent source of novel drug targets and new technologies that can enhance medicinal discovery. Yet many sponsored research collaborations that hope to tap into academia fail.

Drug Development 270

Drug Development 270

STAT

JUNE 15, 2023

The Centers for Disease Control and Prevention report examined the homicide and suicide rates among 10- to 24-year-olds from 2001 to 2021. The homicide rate for older U.S. Read the rest…

244

244

STAT

DECEMBER 12, 2022

The deal is the largest pharma merger announced this year, and it represents the most that Amgen has spent on an acquisition since its $16 billion purchase of Immunex in 2001. Amgen said Monday it would purchase Horizon Pharmaceuticals for $27.8 Continue to STAT+ to read the full story…

Pharmaceutical Companies 250

Pharmaceutical Companies Pharmaceutical Companies 250

STAT

FEBRUARY 13, 2024

In 2001, Gilead secured FDA approval of tenofovir disoproxil fumarate (TDF), one of first medicines to treat HIV — a product still on the market, despite the potential side effect of causing skeletal and kidney damage.

Drug Development 309

Drug Development 309

STAT

AUGUST 8, 2023

The study, published last week in The Lancet Psychiatry , analyzed answers that participants provided between 2001 and 2022 in response to a World Health Organization survey designed to assess the prevalence of major mental health disorders.

246

246

STAT

JANUARY 31, 2023

The program is widely considered a success and has worked well for many drugs, including the leukemia drug Gleevec , which the FDA approved in 2001 after a review period of just two-and-a-half months, based on study results that correctly predicted successful clinical outcomes. Continue to STAT+ to read the full story…

Drug Pricing 242

Drug Pricing 242

STAT

JULY 17, 2023

The study was shut down early — and a year later, prescriptions had plummeted to nearly half what they had been in 2001.  But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease.

243

243

STAT

DECEMBER 12, 2022

The deal is the largest pharmaceutical merger announced this year, and it represents the most that Amgen has spent on an acquisition since its $16 billion purchase of Immunex in 2001. The The product is expected to generate $1.97 billion in 2022 and $2.26 billion in 2023, according to FactSet, an investment data firm.

242

242

STAT

APRIL 11, 2024

stood at 323 during the fourth quarter of last year — the highest figure reached since such data began being tracked in 2001 — underscoring growing concerns about patient harm across the country, STAT tells us. Unresolved The number of ongoing and active drug shortages in the U.S.

Chemotherapy 254

Chemotherapy Immunity Immunization 254

European Pharmaceutical Review

OCTOBER 19, 2023

The Investigational New Drug (IND) application for Intellia Therapeutics’ in vivo CRISPR-based candidate NTLA-2001, has been cleared as a gene editing therapy for transthyretin (ATTR) amyloidosis with cardiomyopathy (ATTR-CM) in the US. This supports NTLA-2001’s potential as a single-administration therapeutic.

105

105

NY Times

DECEMBER 2, 2021

In 2001, U.N. estimates suggested 150 million people would be infected with H.I.V. That preceded an ambitious global campaign to curb the virus. How well did it work?

Immunity 93

Immunity Immunization 93

Express Pharma

DECEMBER 9, 2024

The post Ichnos Glenmark Innovation presents first clinical data from phase 1 study of Trispecific TREAT Antibody, ISB 2001 appeared first on Express Pharma.

Immunity 52

Immunity Immunization Hospitals Labelling 52

PharmaShots

APRIL 3, 2023

REGiMMUNE’s RGI-2001 is currently in P-III trial for the prophylaxis of aGVHD Ref: Businesswire | Image: Regimmune Related News:- Omega Therapeutics Entered into a Clinical Supply Agreement with Roche to Evaluate OTX-2002 for Hepatocellular Carcinoma

40

40

Outsourcing Pharma

JULY 26, 2023

Leslie Orne joined Trinity Life Sciences in 2001 and was recently appointed CEO and president of the fast-growing healthcare consultancy. She previously held the title of chief commercial officer (CCO) and president.

81

81

pharmaphorum

JUNE 28, 2021

Preliminary results from a phase 1 trial run by Regeneron and CRISPR specialist Intellia Therapeutics – co-founded by Nobel Prize winner Jennifer Doudna – showed steep reductions in a biomarker of ATTR amyloidosis disease activity with a single dose of the NTLA-2001 drug.

Packaging 105

Packaging 105

ALiEM - Pharm Pearls

SEPTEMBER 30, 2024

2001 Dec;59(12):1462-70. However, non-traumatic hyphema should prompt investigation for hematologic disorders such as Sickle cell disease. References Brandt MT, Haug RH. Traumatic hyphema: a comprehensive review. J Oral Maxillofac Surg. doi: 10.1053/joms.2001.28284. 2001.28284. PMID: 11732035. Gragg J, Blair K, Baker MB. 2022 Dec 26.

161

161

Pharmaceutical Technology

NOVEMBER 18, 2024

Intellia presented data from its Phase I study of NTLA-2001 at the 2024 American Heart Association scientific meeting in Chicago.

52

52

Pharmacy Times

MAY 8, 2024

Ongoing and active shortages are currently at the highest number since January 2001.

52

52